Literature DB >> 17517841

Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.

Muhamed-Kheir Taha1, Julio A Vázquez, Eva Hong, Desiree E Bennett, Sophie Bertrand, Suzana Bukovski, Mary T Cafferkey, Françoise Carion, Jens Jørgen Christensen, Mathew Diggle, Giles Edwards, Rocío Enríquez, Cecilia Fazio, Matthias Frosch, Sigrid Heuberger, Steen Hoffmann, Keith A Jolley, Marcin Kadlubowski, Amel Kechrid, Konstantinos Kesanopoulos, Paula Kriz, Lotte Lambertsen, Ileanna Levenet, Martin Musilek, Metka Paragi, Aouatef Saguer, Anna Skoczynska, Paola Stefanelli, Sara Thulin, Georgina Tzanakaki, Magnus Unemo, Ulrich Vogel, Maria Leticia Zarantonelli.   

Abstract

Clinical isolates of Neisseria meningitidis with reduced susceptibility to penicillin G (intermediate isolates, Pen(I)) harbor alterations in the penA gene encoding the penicillin binding protein 2 (PBP2). A 402-bp DNA fragment in the 3' half of penA was sequenced from a collection of 1,670 meningococcal clinical isolates from 22 countries that spanned 60 years. Phenotyping, genotyping, and the determination of MICs of penicillin G were also performed. A total of 139 different penA alleles were detected with 38 alleles that were highly related, clustered together in maximum-likelihood analysis and corresponded to the penicillin G-susceptible isolates. The remaining 101 penA alleles were highly diverse, corresponded to different genotypes or phenotypes, and accounted for 38% of isolates, but no clonal expansion was detected. Analysis of the altered alleles that were represented by at least five isolates showed high correlation with the Pen(I) phenotype. The deduced amino acid sequence of the corresponding PBP2 comprised five amino acid residues that were always altered. This correlation was not complete for rare alleles, suggesting that other mechanisms may also be involved in conferring reduced susceptibility to penicillin. Evidence of mosaic structures through events of interspecies recombination was also detected in altered alleles. A new website was created based on the data from this work (http://neisseria.org/nm/typing/penA). These data argue for the use of penA sequencing to identify isolates with reduced susceptibility to penicillin G and as a tool to improve typing of meningococcal isolates, as well as to analyze DNA exchange among Neisseria species.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17517841      PMCID: PMC1932518          DOI: 10.1128/AAC.00412-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  33 in total

1.  Polymorphism of Neisseria meningitidis penA gene associated with reduced susceptibility to penicillin.

Authors:  A Antignac; P Kriz; G Tzanakaki; J M Alonso; M K Taha
Journal:  J Antimicrob Chemother       Date:  2001-03       Impact factor: 5.790

2.  Sequence type analysis and recombinational tests (START).

Authors:  K A Jolley; E J Feil; M S Chan; M C Maiden
Journal:  Bioinformatics       Date:  2001-12       Impact factor: 6.937

3.  Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway.

Authors:  Siamak P Yazdankhah; Paula Kriz; Georgina Tzanakaki; Jenny Kremastinou; Jitka Kalmusova; Martin Musilek; Torill Alvestad; Keith A Jolley; Daniel J Wilson; Noel D McCarthy; Dominique A Caugant; Martin C J Maiden
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

4.  Automation of MLST using third-generation liquid-handling technology.

Authors:  C B Sullivan; J M C Jefferies; M A Diggle; S C Clarke
Journal:  Mol Biotechnol       Date:  2006-03       Impact factor: 2.695

5.  Semiautomation of multilocus sequence typing for the characterization of clinical isolates of Neisseria meningitidis.

Authors:  S C Clarke; M A Diggle; G F Edwards
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

6.  Mechanisms other than penicillin-binding protein-2 alterations may contribute to moderate penicillin resistance in Neisseria meningitidis.

Authors:  P Orús; M Viñas
Journal:  Int J Antimicrob Agents       Date:  2001-08       Impact factor: 5.283

7.  Total variation in the penA gene of Neisseria meningitidis: correlation between susceptibility to beta-lactam antibiotics and penA gene heterogeneity.

Authors:  Sara Thulin; Per Olcén; Hans Fredlund; Magnus Unemo
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

Review 8.  Diagnosis and management of meningococcal disease: the need for centralized care.

Authors:  Simon Nadel; J Simon Kroll
Journal:  FEMS Microbiol Rev       Date:  2007-01       Impact factor: 16.408

9.  Interlaboratory comparison of PCR-based methods for detection of penicillin G susceptibility in Neisseria meningitidis.

Authors:  Muhamed-Kheir Taha; Maria Leticia Zarantonelli; Arianna Neri; Rocío Enriquez; Julio A Vázquez; Paola Stefanelli
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

Review 10.  Population genetics and molecular epidemiology of Neisseria meningitidis.

Authors:  D A Caugant
Journal:  APMIS       Date:  1998-05       Impact factor: 3.205

View more
  40 in total

1.  Resolution of a meningococcal disease outbreak from whole-genome sequence data with rapid Web-based analysis methods.

Authors:  Keith A Jolley; Dorothea M C Hill; Holly B Bratcher; Odile B Harrison; Ian M Feavers; Julian Parkhill; Martin C J Maiden
Journal:  J Clin Microbiol       Date:  2012-07-11       Impact factor: 5.948

2.  Combined real-time PCR and pyrosequencing strategy for objective, sensitive, specific, and high-throughput identification of reduced susceptibility to penicillins in Neisseria meningitidis.

Authors:  Sara Thulin; Per Olcén; Hans Fredlund; Magnus Unemo
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191

3.  Neisseria meningitidis disease-associated clones in Amazonas State, Brazil.

Authors:  Luciete A Silva; Beatriz Coronato; Jessica Schlackman; Jane W Marsh; Chinelo Ezeonwuka; Andréia C L Fernandes; Victor C Souza; Lirna S da Silva; Elaine F Q de Amorim; Felipe G Naveca; Bernardino C de Albuquerque; Alcirene Amaral; Ana L S Souza; Filipe A Carvalho-Costa; Mustapha M Mustapha; Lee H Harrison; David E Barroso
Journal:  Infect Dis (Lond)       Date:  2018-04-06

Review 4.  Evolutionary and genomic insights into meningococcal biology.

Authors:  Holly B Bratcher; Julia S Bennett; Martin C J Maiden
Journal:  Future Microbiol       Date:  2012-07       Impact factor: 3.165

5.  Evolutionary changes in antimicrobial resistance of invasive Neisseria meningitidis isolates in Belgium from 2000 to 2010: increasing prevalence of penicillin nonsusceptibility.

Authors:  Sophie Bertrand; Françoise Carion; René Wintjens; Vanessa Mathys; Raymond Vanhoof
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

6.  Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives.

Authors:  Sara Thulin Hedberg; Hans Fredlund; Pierre Nicolas; Dominique A Caugant; Per Olcén; Magnus Unemo
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

7.  Target gene sequencing to define the susceptibility of Neisseria meningitidis to ciprofloxacin.

Authors:  Eva Hong; Sara Thulin Hedberg; Raquel Abad; Cecilia Fazio; Rocío Enríquez; Ala-Eddine Deghmane; Keith A Jolley; Paola Stefanelli; Magnus Unemo; Julio A Vazquez; Frédéric J Veyrier; Muhamed-Kheir Taha
Journal:  Antimicrob Agents Chemother       Date:  2013-01-28       Impact factor: 5.191

8.  Meningococcal Quinolone Resistance Originated from Several Commensal Neisseria Species.

Authors:  Mingliang Chen; Chi Zhang; Xi Zhang; Min Chen
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

9.  Use of Animal Models To Support Revising Meningococcal Breakpoints of β-Lactams.

Authors:  Nouria Belkacem; Eva Hong; Ana Antunes; Aude Terrade; Ala-Eddine Deghmane; Muhamed-Kheir Taha
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

10.  Serogroup C meningococci in Italy in the era of conjugate menC vaccination.

Authors:  Paola Stefanelli; Cecilia Fazio; Tonino Sofia; Arianna Neri; Paola Mastrantonio
Journal:  BMC Infect Dis       Date:  2009-08-22       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.